Literature DB >> 24375454

The DNA damage response induces antigen presenting cell-like functions in fibroblasts.

Melissa Li Fang Tang1, Muznah Khatoo Nazar Khan, John Ludovic Croxford, Kar Wai Tan, Veronique Angeli, Stephan Gasser.   

Abstract

The DNA damage response (DDR) alerts the immune system to the danger posed by DNA damage through the induction of damage-associated molecular pattern molecules, chemokines, and ligands for activating immune receptors such as lymphocyte function-associated antigen 1 (LFA-1), NKG2D, and DNAX accessory molecule 1 (DNAM-1). Here we provide evidence that OVA(257-264) -pulsed fibroblasts gain the ability to activate naïve OT-I CD8(+) T cells in response to DNA damage. The ability of fibroblasts to activate OT-I CD8(+) T cells depended on the upregulation of ICAM-1 on fibroblasts and DNAM-1 expression of CD8(+) T cells. OVA(257-264) -pulsed fibroblasts were able to induce a protective T-cell response against B16-OVA cells in a DDR-dependent manner. Hence, the DDR may alert the immune system to the presence of potentially dangerous cells by upregulating the expression of ligands that can induce the activation of innate and adaptive immune cells.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Adaptive immunity; Antigen-presenting cell; Chemotherapy; DNA damage; Fibroblasts

Mesh:

Substances:

Year:  2014        PMID: 24375454     DOI: 10.1002/eji.201343781

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

Review 1.  Cellular senescence: from growth arrest to immunogenic conversion.

Authors:  D G A Burton; R G A Faragher
Journal:  Age (Dordr)       Date:  2015-03-20

2.  Local Expression of Indoleamine 2,3, Dioxygenase Prolongs Allogenic Skin Graft Take in a Mouse Model.

Authors:  Mohammadreza Pakyari; Ali Farokhi; Reza B Jalili; Ruhangiz T Kilani; Erin Brown; Aziz Ghahary
Journal:  Adv Wound Care (New Rochelle)       Date:  2019-02-13       Impact factor: 4.730

Review 3.  Mechanisms regulating immune surveillance of cellular stress in cancer.

Authors:  Ruth Seelige; Stephen Searles; Jack D Bui
Journal:  Cell Mol Life Sci       Date:  2017-07-25       Impact factor: 9.261

4.  TP53-dependent autophagy links the ATR-CHEK1 axis activation to proinflammatory VEGFA production in human bronchial epithelial cells exposed to fine particulate matter (PM2.5).

Authors:  Xiuduan Xu; Hongli Wang; Shasha Liu; Chen Xing; Yang Liu; Wei Zhou; Xiaoyan Yuan; Yongfu Ma; Meiru Hu; Yongliang Hu; Shuxian Zou; Ye Gu; Shuangqing Peng; Shengtao Yuan; Weiping Li; Yuanfang Ma; Lun Song
Journal:  Autophagy       Date:  2016-07-27       Impact factor: 16.016

5.  New perspective on targeting the tumor suppressor p53 pathway in the tumor microenvironment to enhance the efficacy of immunotherapy.

Authors:  Gang Guo; Yan Cui
Journal:  J Immunother Cancer       Date:  2015-03-24       Impact factor: 13.751

Review 6.  Emerging treatment options for ovarian cancer: focus on rucaparib.

Authors:  Lavanya Mariappan; Xue Yan Jiang; Josie Jackson; Yvette Drew
Journal:  Int J Womens Health       Date:  2017-12-15

Review 7.  Combining DNA damaging therapeutics with immunotherapy: more haste, less speed.

Authors:  Jessica S Brown; Raghav Sundar; Juanita Lopez
Journal:  Br J Cancer       Date:  2017-11-09       Impact factor: 7.640

Review 8.  Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application.

Authors:  Hongyu Xie; Wenjie Wang; Wencai Qi; Weilin Jin; Bairong Xia
Journal:  Front Immunol       Date:  2021-10-12       Impact factor: 7.561

Review 9.  The Interplay between PARP Inhibitors and Immunotherapy in Ovarian Cancer: The Rationale behind a New Combination Therapy.

Authors:  Brigida Anna Maiorano; Domenica Lorusso; Mauro Francesco Pio Maiorano; Davide Ciardiello; Paola Parrella; Antonio Petracca; Gennaro Cormio; Evaristo Maiello
Journal:  Int J Mol Sci       Date:  2022-03-31       Impact factor: 5.923

10.  8-Oxoguanine DNA Glycosylase (OGG1) Deficiency Exacerbates Doxorubicin-Induced Cardiac Dysfunction.

Authors:  Chukwuemeka George Anene-Nzelu; Peter Yiqing Li; Tuan Danh Anh Luu; Shi Ling Ng; Zenia Tiang; Bangfen Pan; Wilson Lek Wen Tan; Matthew Ackers-Johnson; Ching Kit Chen; Yee Phong Lim; Rina Wang Miao Qin; Wee Woon Chua; Lim Xin Yi; Roger Sik-Yin Foo; Yusaku Nakabeppu
Journal:  Oxid Med Cell Longev       Date:  2022-03-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.